{"id":"cefazolin-erythromycin-clarithromycin","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbance"},{"rate":null,"effect":"Hypersensitivity reaction"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Cefazolin is a first-generation cephalosporin that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. Erythromycin and clarithromycin are macrolide antibiotics that inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit. The combination provides broad-spectrum coverage against gram-positive and some gram-negative bacteria.","oneSentence":"This is a combination of three antibiotics that work through different mechanisms to inhibit bacterial protein synthesis and cell wall formation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:05:10.082Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections (specific indication unclear from available information)"}]},"trialDetails":[{"nctId":"NCT01503606","phase":"PHASE3","title":"Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2011-10","conditions":"Preterm Premature Rupture of Membrane","enrollment":151},{"nctId":"NCT01401179","phase":"PHASE3","title":"Antibiotics Study in Preterm Premature Rupture of the Membranes","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2005-04","conditions":"Preterm Premature Rupture of the Membranes","enrollment":101}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"cefazolin, erythromycin, clarithromycin","genericName":"cefazolin, erythromycin, clarithromycin","companyName":"Samsung Medical Center","companyId":"samsung-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a combination of three antibiotics that work through different mechanisms to inhibit bacterial protein synthesis and cell wall formation. Used for Bacterial infections (specific indication unclear from available information).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}